Skip to main content

Animations

MJFF Publications

3861 - 3870 of 6534 Results
Title
Year
  • Year
  • 2023
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106343
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Toward preventing Parkinson’s disease
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.add7162
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Unveiling the B cell receptor structure
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.add8065
    Citation Count: 13
  • Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication response
    2022
    Summary Details
    OPEN
    Title: Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication response
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.adc9669
    Citation Count: 105
  • Summary Details
    OPEN
    Title: Optimization of Lipophilic Metalloporphyrins Modifies Disease Outcomes in a Rat Model of Parkinsonism
    Journal Name: The Journal of Pharmacology and Experimental Therapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1124/jpet.120.000229
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype
    Journal Name: American Journal of Alzheimer's Disease & Other Dementias®
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1177/1533317520981225
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Teaching Video NeuroImage: “Weighing” in on an Unusual Tremor
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012141
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Quality Improvement in Neurology
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012198
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study
    Journal Name: Journal of the American Psychiatric Nurses Association
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/10783903211023565
    Citation Count: 17
  • Summary Details
    OPEN
    Title: ECTRIMS 2021 – Late Breaking News ePoster
    Journal Name: Multiple Sclerosis Journal
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/13524585211047080
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.